SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000904454-20-000171
Filing Date
2020-02-13
Accepted
2020-02-13 16:53:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCH 13G/A FILING FOR MFN PARTNERS (FILER) AND ISSUER ACLARIS, TO BE FILED IN FEB s13ga_021020-aclaris.htm SC 13G/A 125332
  Complete submission text file 0000904454-20-000171.txt   126785
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89137 | Film No.: 20611605
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116 617-443-2040
MFN Partners Management, LP (Filed by) CIK: 0001732811 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A